Journal article
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study
B Williams, J Howell, J Doyle, AJ Thompson, B Draper, C Layton, N Latham, F Bramwell, D Membrey, M Mcpherson, J Roney, M Stoové, ME Hellard, A Pedrana
International Journal of Drug Policy | ELSEVIER | Published : 2019
Abstract
Background: Achieving hepatitis C elimination requires novel approaches to engage people at highest risk of infection into care pathways. Point-of-care-tests may help to overcome some of the barriers preventing people who inject drugs (PWID) accessing testing and progressing to treatment for hepatitis C virus (HCV). We assessed the feasibility and acceptability of HCV point-of-care testing at needle and syringe exchange programs (NSPs) co-located in three community health clinics in Melbourne, Australia. Methods: NSP clients were offered an oral fluid point-of-care test for HCV antibody by NSP staff. Positive HCV antibody tests were followed by a point-of-care test for HCV RNA alongside stan..
View full abstract